Jetfuel vitamin drips boost you through long COVID
Even though more than 92% of South Africans making a complete recovery after being ill with COVID-19, that recovery can take a long time, with some even struggling with what’s been dubbed ‘lo-co’, or ‘long COVID’ – but there are indications that help may be at hand for them.
While the normal period of illness when suffering from COVID-19 is two to three weeks, long COVID sufferers display a range of continuing physical and psychological symptoms for months after their initial infection – and because the disease hasn’t been around for that long, it’s not yet known how likely these symptoms are to stay.
Symptoms could be caused by organ damage to the lung, heart, or kidney, or by the physical stress of a long ICU stay, and include fatigue, breathlessness, a persistent cough, joint pain and affected hearing, eyesight, smell and taste. Many also struggle from depression, anxiety, and brain fog.
And doctors have found no link between the severity of a person’s infection, and the levels of fatigue they experience long after they’ve apparently recovered. So even those with mild symptoms may experience symptoms for some time to come.
However, some people struggling with long COVID have found that a Jetfuel drip administered twice a month helps manage long COVID symptoms, particularly the fatigue.
A Jetfuel includes Vitamin B12, Vitamin B Complex, Magnesium Sulphate, Glutathione and Vitamin C, as well as electrolytes and rehydrating fluids for an added boost. It has been reported to improve energy levels, the immune system and mood, and helps you get up and start returning back to normality – something that we all long for after 2020!
Contact your nearest IV Bar branch in Johannesburg, Centurion, Pretoria, or Cape Town to book your Jetfuel drip, or just pop in, walk-ins are always welcome. We can also send one of our registered nurses to administer the drip at your home or office.
Our drips are medically approved and administered by Registered Nurses. Vitamin drips cannot be administered to pregnant or breastfeeding women, and to people with severe kidney dysfunction.